Deep learning in GPCR drug discovery: benchmarking the path to accurate peptide binding.

Brief Bioinform · 2025 · PMC12031724 · PMID 40285358

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In terms of classification, the models showed a trend of improved ranking for class B1 over class A GPCRs ( Fig. 3d ), which likely resulted from the complete structural coverage of class B1 receptors [ 26 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.